HILLEVAX INC's ticker is and the CUSIP is 43157M102. A total of 62 filers reported holding HILLEVAX INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,117,326 | -4.4% | 826,567 | +22.2% | 2.48% | +15.2% |
Q2 2023 | $11,630,221 | +4.0% | 676,569 | 0.0% | 2.15% | +3.5% |
Q1 2023 | $11,183,686 | -1.2% | 676,569 | +0.0% | 2.08% | +40.7% |
Q4 2022 | $11,318,966 | -2.1% | 676,567 | 0.0% | 1.48% | -10.2% |
Q3 2022 | $11,563,000 | +56.4% | 676,567 | 0.0% | 1.64% | +107.8% |
Q2 2022 | $7,395,000 | – | 676,567 | – | 0.79% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Qiming U.S. Ventures Management, LLC | 558,923 | $9,350,782 | 12.37% |
Frazier Life Sciences Management, L.P. | 9,758,359 | $163,257,346 | 10.15% |
Abingworth LLP | 1,838,486 | $30,757,871 | 10.02% |
Samsara BioCapital, LLC | 610,062 | $10,206,337 | 2.20% |
StepStone Group LP | 676,567 | $11,318,966 | 1.48% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,694,101 | $45,072,310 | 0.93% |
BRAIDWELL LP | 1,620,216 | $27,106,214 | 0.91% |
RA Capital Management | 1,760,019 | $29,445,118 | 0.60% |
Perceptive Advisors | 406,024 | $6,792,782 | 0.19% |
BVF INC/IL | 248,579 | $4,158,727 | 0.18% |